The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BLLN · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
SNWV · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | GILD | PDEX | BLLN | SNWV |
|---|---|---|---|---|
| Moat Score (0–100) | 71 | 72 (highest) | 72 (highest) | 71 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 90 (highest) | 85 | 75 |
| Pricing power | 99 (highest) | 44 | 59 | 87 |
| Returns on capital | 100 (highest) | 62 | — | — |
| Balance-sheet safety | 47 | 65 | 100 (highest) | 77 |
| Capital discipline | 39 | 100 (highest) | 44 | 44 |
| Price vs. high estimate | 16% above high estimate (largest discount to high estimate) | 61% above high estimate | No price data | No price data |
| Market cap | $160.5B | $179M | $2.7B | $50.9M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |